Cannabidiol Hydroxyquinone

CAS: 137252-25-6

Ref. TR-C175315

Informação sobre produto

• Nome: Cannabidiol Hydroxyquinone
• Sinónimos: Cannabidiol hydroxyquinone (CBDHQ), 2,5-Cyclohexadiene-1,4-dione, 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-, 2,5-Cyclohexadiene-1,4-dione, 3-hydroxy-2-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-, (1R-trans)-, 3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione, HU 331, VCE 004, (3S,4R)-3-Hydroxy-2-p-mentha-(1,8)-dien-3-yl-5-pentyl-3,4-p-benzoquinone, (6'R)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-1,1'-bi(cyclohexane)-2',3,6-triene-2,5-dione, 2,5-Cyclohexadiene-1,4-dione, 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-, 2,5-Cyclohexadiene-1,4-dione, 3-hydroxy-2-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-, (1R-trans)-, Hu-331, Vce 004
• CAS: 137252-25-6

Descrição

Stability Light Sensitive
Applications A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than Doxorubicin and thus it has a high potential for development as a new anticancer drug.
References Dana, B., et al.: J. Clin. Oncol., 11, 644 (1993), Feleszko, W., et al.: Clin. Cancer Res., 6, 2044 (2000), Kogan, N., et al.: J. Med. Chem., 47, 3800 (2004),

• Marca: TRC

Propriedades químicas

• Peso molecular: 328.50
• Fórmula: C₂₁H₂₈O₃
• Cor/forma: Neat
• InChI: InChI=1S/C21H28O3/c1-5-6-7-8-15-12-18(22)19(21(24)20(15)23)17-11-14(4)9-10-16(17)13(2)3/h11-12,16-17,24H,2,5-10H2,1,3-4H3/t16-,17+/m0/s1
• Chave InChI: InChIKey=WDXXEUARVHTWQF-DLBZAZTESA-N
• SMILES: C=C(C)[C@@H]1CCC(C)=C[C@H]1C1=C(O)C(=O)C(CCCCC)=CC1=O